National Cancer Institute; Notice of Closed Meeting, 36540-36541 [2014-15061]
Download as PDF
36540
Federal Register / Vol. 79, No. 124 / Friday, June 27, 2014 / Notices
(Petitioner’s Name v. Secretary of Health
and Human Services) and the docket
number assigned to the petition should
be used as the caption for the written
submission. Chapter 35 of title 44,
United States Code, related to
paperwork reduction, does not apply to
information required for purposes of
carrying out the Program.
Dated: June 20, 2014.
Mary K. Wakefield,
Administrator.
wreier-aviles on DSK5TPTVN1PROD with NOTICES
List of Petitions Filed
1. Lauren E. Neeley, Boynton Beach, Florida,
Court of Federal Claims No: 14–0373V.
2. Brandy Williams on behalf of LS, Gilbert,
Arizona, Court of Federal Claims No: 14–
0375V.
3. James Clark, Winchester, Massachusetts,
Court of Federal Claims No: 14–0379V.
4. Angie F. French and Dan French on behalf
of V.F., Phoenix, Arizona, Court of
Federal Claims No: 14–0383V.
5. Gary Martz, Tempe, Arizona, Court of
Federal Claims No: 14–0384V.
6. Reta Erxleben, Cincinnati, Ohio, Court of
Federal Claims No: 14–0385V.
7. Markelle D. Vickers, Antioch, California,
Court of Federal Claims No: 14–0386V.
8. Amy M. Nesbitt and Eric L. Nesbitt on
behalf of MNN, Moline, Illinois, Court of
Federal Claims No: 14–0392V.
9. Sheri Swigert, Lincoln, California, Court of
Federal Claims No: 14–0395V.
10. Danielle N. Meyer, Knoxville, Tennessee,
Court of Federal Claims No: 14–0399V.
11. James Rowden, Fort Benning, Georgia,
Court of Federal Claims No: 14–0400V.
12. Steve H. Mitchell, Shreveport, Louisiana,
Court of Federal Claims No: 14–0401V.
13. Lissa Garcia on behalf of Stefon Garcia,
Deceased, Brownsville, Texas, Court of
Federal Claims No: 14–0404V.
14. John Ciprus, Wethersfield, Connecticut,
Court of Federal Claims No: 14–0410V.
15. Danny Wilson, St. Louis, Missouri, Court
of Federal Claims No: 14–0411V.
16. Daniel Webb, Atlanta, Georgia, Court of
Federal Claims No: 14–0412V.
17. Ivanka Pentcholov on behalf of Athena
Pentcholov, Seattle, Washington, Court
of Federal Claims No: 14–0414V.
18. Sonal Patel, New Haven, Connecticut,
Court of Federal Claims No: 14–0421V.
19. Tammy Schettl, Olmstead County,
Minnesota, Court of Federal Claims No:
14–0422V.
20. Chun-Xiang Mao, El Paso, Texas, Court of
Federal Claims No: 14–0426V.
21. Jenelle and Arturo Escalera on behalf of
Alivia Escalera, Phoenix, Arizona, Court
of Federal Claims No: 14–0431V.
22. Kristin Mehner, Cape Girardeau,
Missouri, Court of Federal Claims No:
14–0432V.
23. Michelle Stoke, Memphis, Tennessee,
Court of Federal Claims No: 14–0433V.
24. Larry Johnston on behalf of Evan
Johnston, Avon, Ohio, Court of Federal
Claims No: 14–0434V.
25. Laura Mitchell, Laurel, Maryland, Court
of Federal Claims No: 14–0438V.
26. Leigh Rolshoven on behalf of Hannah
VerDate Mar<15>2010
15:30 Jun 26, 2014
Jkt 232001
Huelsenbeck, Windom, Minnesota, Court
of Federal Claims No: 14–0439V.
27. Jennifer Gowans and Mitchell Gowans on
behalf of Ivy E. Gowans, Rehoboth,
Massachusetts, Court of Federal Claims
No: 14–0440V.
28. Leslie C. Potts, Jr., Grant, Nebraska, Court
of Federal Claims No: 14–0441V.
29. Angela Allard, Jackson, California, Court
of Federal Claims No: 14–0442V.
30. Jody Hupe on behalf of B.A.H.,
Manhattan, Kansas, Court of Federal
Claims No: 14–0448V.
31. Richard Berrish, Freeport, Pennsylvania,
Court of Federal Claims No: 14–0453V.
32. Barbara Wright, Winchester, Virginia,
Court of Federal Claims No: 14–0454V.
33. Erin Menser, Seattle, Washington, Court
of Federal Claims No: 14–0455V.
34. Julie Jones, Birmingham, Alabama, Court
of Federal Claims No: 14–0456V.
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: June 23, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–15062 Filed 6–26–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–15047 Filed 6–26–14; 8:45 am]
National Institutes of Health
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Outstanding New
Environmental Scientist Review Meeting.
Date: July 22, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Environmental
Health Sciences, Rall Building, Room 101,
ABC, 111 T. W. Alexander Drive, Research
Triangle Park, NC 27713.
Contact Person: Janice B. Allen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, Nat. Inst. of Environmental Health
Sciences, P.O. Box 12233, MD EC–30/Room
3170 B, Research Triangle Park, NC 27709,
919/541–7556.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Feasibility
Studies to Build Collaborative Partnerships
in Cancer Research (P20).
Date: July 22–23, 2014.
Time: 5:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Christopher L. Hatch,
Ph.D., Chief, Health Scientist Administrator,
Program Coordination & Referral Branch,
Division of Extramural Activities, National
Cancer Institute, 9609 Medical Center Drive,
Room 7W554, Rockville, MD 20850, 240–
276–6454, ch29v@nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
E:\FR\FM\27JNN1.SGM
27JNN1
Federal Register / Vol. 79, No. 124 / Friday, June 27, 2014 / Notices
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: June 24, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–15061 Filed 6–26–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
wreier-aviles on DSK5TPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–13–
182: Drug Abuse Dissertation Research.
Date: July 8, 2014.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Mary Clare Walker, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5208,
MSC 7852, Bethesda, MD 20892, (301) 435–
1165, walkermc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, [PAR] 14–
073 Shared Instrumentation: Review of X-ray
diffraction systems and/or NMR
spectrometers.
Date: July 14–15, 2014.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Albert Wang, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4146, MSC 7806, Bethesda, MD
20892, 301–435–1016, wangca@csr.nih.gov.
VerDate Mar<15>2010
15:30 Jun 26, 2014
Jkt 232001
Name of Committee: AIDS and Related
Research Integrated Review Group,
NeuroAIDS and Other End-Organ Diseases
Study Section.
Date: July 21, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Kinzie Hotel, Twenty West Kinzie
Street, Chicago, IL 60654.
Contact Person: Eduardo A. Montalvo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7852, Bethesda, MD 20892, (301) 435–
1168, montalve@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Fellowships: Biochemistry and Biophysical
Chemistry.
Date: July 21–22, 2014.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: David R. Jollie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
MSC 7806, Bethesda, MD 20892, (301) 437–
7927, jollieda@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 23, 2014.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–15059 Filed 6–26–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
36541
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Immunopathology and
Immunotherapy.
Date: July 21, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Lawrence Ka-Yun Ng,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152,
MSC 7804, Bethesda, MD 20892, 301–435–
1719, ngkl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Neuropharmacology.
Date: July 21, 2014.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Richard D. Crosland,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190,
MSC 7850, Bethesda, MD 20892, 301–435–
1220, crosland@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–RM–
13–019: Broadening Experiences in Scientific
Training (DP7/BEST) Panel 2.
Date: July 24, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Lawrence E. Boerboom,
Ph.D., Chief, CVRS IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4130, MSC 7814,
Bethesda, MD 20892, (301) 435–8367,
boerboom@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Hypertension and Thrombosis.
Date: July 24–25, 2014.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Luis Espinoza, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7814, Bethesda, MD 20892, 301–435–
0952, espinozala@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Communication and Motor
Function.
Date: July 24, 2014.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\27JNN1.SGM
27JNN1
Agencies
[Federal Register Volume 79, Number 124 (Friday, June 27, 2014)]
[Notices]
[Pages 36540-36541]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-15061]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Feasibility Studies to Build Collaborative Partnerships in
Cancer Research (P20).
Date: July 22-23, 2014.
Time: 5:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center,
Montgomery County Conference Center Facility, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Christopher L. Hatch, Ph.D., Chief, Health
Scientist Administrator, Program Coordination & Referral Branch,
Division of Extramural Activities, National Cancer Institute, 9609
Medical Center Drive, Room 7W554, Rockville, MD 20850, 240-276-6454,
ch29v@nih.gov.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and
[[Page 36541]]
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396,
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398,
Cancer Research Manpower; 93.399, Cancer Control, National
Institutes of Health, HHS)
Dated: June 24, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-15061 Filed 6-26-14; 8:45 am]
BILLING CODE 4140-01-P